Reneo Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RPHM and buy or sell other stocks, ETFs, and their options commission-free!About RPHM
OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer.
CEONicholas A. Saccomano, PhD
CEONicholas A. Saccomano, PhD
Employees46
Employees46
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded
Founded
Employees46
Employees46
RPHM Key Statistics
Market cap24.62M
Market cap24.62M
Price-Earnings ratio-10.80
Price-Earnings ratio-10.80
Dividend yield—
Dividend yield—
Average volume35.89K
Average volume35.89K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$92.10
52 Week high$92.10
52 Week low$9.80
52 Week low$9.80
Stock Snapshot
Reneo Pharmaceuticals(RPHM) stock is priced at $1.82, giving the company a market capitalization of 24.62M. It carries a P/E multiple of -10.80.
On 2025-11-05, Reneo Pharmaceuticals(RPHM) stock opened at —, reached a high of —, and a low of —.
Reneo Pharmaceuticals(RPHM) shares are trading with a volume of 0, against a daily average of 35.89K.
In the last year, Reneo Pharmaceuticals(RPHM) shares hit a 52-week high of $92.10 and a 52-week low of $9.80.
In the last year, Reneo Pharmaceuticals(RPHM) shares hit a 52-week high of $92.10 and a 52-week low of $9.80.
People also own
Based on the portfolios of people who own RPHM. This list is generated using Robinhood data, and it’s not a recommendation.